BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 7479774)

  • 1. Modulation of cholecystokinin activity by albumin.
    Huang SC; Talkad VD; Fortune KP; Jonnalagadda S; Severi C; Delle Fave G; Gardner JD
    Proc Natl Acad Sci U S A; 1995 Oct; 92(22):10312-6. PubMed ID: 7479774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzodiazepine analogues L365,260 and L364,718 as gastrin and pancreatic CCK receptor antagonists.
    Huang SC; Zhang L; Chiang HC; Wank SA; Maton PN; Gardner JD; Jensen RT
    Am J Physiol; 1989 Jul; 257(1 Pt 1):G169-74. PubMed ID: 2473653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical regulation of the three different states of the cholecystokinin (CCK) receptor in pancreatic acini.
    Pandya PK; Huang SC; Talkad VD; Wank SA; Gardner JD
    Biochim Biophys Acta; 1994 Oct; 1224(1):117-26. PubMed ID: 7948036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the three different states of the cholecystokinin (CCK) receptor in pancreatic acini.
    Talkad VD; Patto RJ; Metz DC; Turner RJ; Fortune KP; Bhat ST; Gardner JD
    Biochim Biophys Acta; 1994 Oct; 1224(1):103-16. PubMed ID: 7524683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic receptors for cholecystokinin: evidence for three receptor classes.
    Yu DH; Huang SC; Wank SA; Mantey S; Gardner JD; Jensen RT
    Am J Physiol; 1990 Jan; 258(1 Pt 1):G86-95. PubMed ID: 2301586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct demonstration of three different states of the pancreatic cholecystokinin receptor.
    Talkad VD; Fortune KP; Pollo DA; Shah GN; Wank SA; Gardner JD
    Proc Natl Acad Sci U S A; 1994 Mar; 91(5):1868-72. PubMed ID: 8127897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Properties of receptors for gastrin and CCK on gastric smooth muscle cells.
    Menozzi D; Gardner JD; Jensen RT; Maton PN
    Am J Physiol; 1989 Jul; 257(1 Pt 1):G73-9. PubMed ID: 2473654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of cholecystokinin receptors on the human gallbladder.
    Tokunaga Y; Cox KL; Coleman R; Concepcion W; Nakazato P; Esquivel CO
    Surgery; 1993 Feb; 113(2):155-62. PubMed ID: 7679224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of CCK receptors in a novel smooth muscle preparation from the guinea-pig stomach by use of the selective antagonists CI-988, L-365,260 and devazepide.
    Boyle SJ; Tang KW; Woodruff GN; McKnight AT
    Br J Pharmacol; 1993 Aug; 109(4):913-7. PubMed ID: 8401944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cibacron blue-induced enhancement of agonist binding to cholecystokinin (CCK) receptors in solubilized pancreatic membranes.
    Yuan DS; Wank SA; Gardner JD
    Biochim Biophys Acta; 1993 Feb; 1146(1):52-8. PubMed ID: 8443227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonist.
    Chang RS; Lotti VJ
    Proc Natl Acad Sci U S A; 1986 Jul; 83(13):4923-6. PubMed ID: 3014520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Both CCK-A and CCK-B/gastrin receptors mediate pepsinogen release in guinea pig gastric glands.
    Lin CW; Bianchi BR; Miller TR; Witte DG; Wolfram CA
    Am J Physiol; 1992 Jun; 262(6 Pt 1):G1113-20. PubMed ID: 1616041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of cholecystokinin receptors on the sphincter of Oddi.
    Cox KL; von Schrenck T; Moran TH; Gardner JD; Jensen RT
    Am J Physiol; 1990 Nov; 259(5 Pt 1):G873-81. PubMed ID: 2240227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleoside diphosphate kinase associated with rat pancreatic membranes regulates CCK receptor affinity.
    Blevins GT; van de Westerlo EM; Williams JA
    Am J Physiol; 1994 Nov; 267(5 Pt 1):G866-74. PubMed ID: 7977749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic profile of TS-941, a new benzodiazepine derivative cholecystokinin-receptor antagonist, in in vitro isolated rat pancreatic acini.
    Tashiro M; Hirohata Y; Kihara Y; Akiyama T; Otsuki M
    Pancreas; 1999 Mar; 18(2):156-64. PubMed ID: 10090413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCK-JMV-180: a peptide that distinguishes high-affinity cholecystokinin receptors from low-affinity cholecystokinin receptors.
    Stark HA; Sharp CM; Sutliff VE; Martinez J; Jensen RT; Gardner JD
    Biochim Biophys Acta; 1989 Feb; 1010(2):145-50. PubMed ID: 2463851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholecystokinin receptor characterization and cholecystokinin-A receptor messenger RNA expression in transgenic mouse pancreatic carcinomas and dysplastic pancreas.
    Povoski SP; Zhou W; Longnecker DS; Bell RH
    Oncol Res; 1994; 6(9):411-7. PubMed ID: 7703527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of cholecystokinin receptors on guinea pig gastric chief cell membranes.
    Matozaki T; Sakamoto C; Nagao M; Nishisaki H; Konda Y; Nakano O; Matsuda K; Wada K; Suzuki T; Kasuga M
    Biochem Biophys Res Commun; 1991 Feb; 174(3):1055-63. PubMed ID: 1996975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation and recycling of high affinity cholecystokinin receptors on pancreatic acinar cells.
    Menozzi D; Vinayek R; Jensen RT; Gardner JD
    J Biol Chem; 1991 Jun; 266(16):10385-91. PubMed ID: 2037588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cholecystokinin (CCK)-JMV-180 on the CCK receptors of rabbit pancreatic acini and gallbladder smooth muscle.
    Taniguchi H; Nagasaki M; Tamaki H
    Jpn J Pharmacol; 1995 Mar; 67(3):219-24. PubMed ID: 7543168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.